🔎 Trials Near Me

Inicio › Depresión › Washington

Ensayos clínicos de Depresión en Washington

20 estudios sobre Depresión buscan participantes en Washington.

Ciudades en Washington

Texto oficial del estudio (inglés)

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  • Core Clinical Research, Everett
  • Seattle Neuropsychiatric Treatment Center, Seattle
ReclutandoFase 3
Edades de 18 a 85 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06793397

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Seattle Neuropsychiatric Treatment Center, Seattle
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07002034

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

  • Seaport Investigator Site, Everett
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 14 sept 2026 · NCT07065240

PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study

  • Seattle NTC, Seattle
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06713616

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

  • Draig Clinical Site, Bellevue
  • Draig Clinical Site, Seattle
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

  • Draig Clinical Site, Bellevue
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 26 ago 2026 · NCT07300969

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 14 ago 2026 · NCT07226232

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  • Northwest Clinical Research Center, Bellevue
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 6 ago 2026 · NCT07412756

E-Mindfulness Approaches for Living After Breast Cancer

  • Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale
ReclutandoFase 3
Edades de 18 a 50 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06748222

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  • Core Clinical Research, Everett
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06775379

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Everett
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 jul 2026 · NCT06966401

CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms

  • Madigan Army Medical Center, Fort Lewis
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 jul 2026 · NCT05663034

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

  • Seattle Children's Hospital, Seattle
ReclutandoEstudio observacional
18 Months – 11 Years · Todos los sexos · Actualizado el 6 jul 2026 · NCT07048574

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

  • Center For Anxiety and Depression, Mercer Island
  • Seattle Neuropsychiatric Treatment Center, Seattle
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 jun 2026 · NCT03887715

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • Seattle Neuropsychiatric Treatment Center, Bellevue
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 11 may 2026 · NCT06524830

Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

  • Seattle Children's Hospital, Seattle
Reclutando
Edades de 12 a 22 · Todos los sexos · Actualizado el 30 oct 2025 · NCT06232304

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Everett
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2025 · NCT06786624

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

  • Clinical Research Site, Everett
ReclutandoFase 4
Edades de 18 a 65 · Todos los sexos · Actualizado el 23 ene 2025 · NCT06223880

Lay-Delivered Behavioral Activation in Senior Centers

  • Enumclaw Senior Center, Enumclaw
  • Casa Latina, Seattle
  • Centro de la Raza, Seattle
  • y 1 más
Reclutando
Edades de 60 en adelante · Todos los sexos · Actualizado el 15 oct 2024 · NCT04621877

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.